Dr. Robert Brookins
Chief Executive OfficerRobert (Bob) Brookins, Ph.D., M.A.E. B.A. B.Sc is the Chief Executive Officer. Dr. Brookins has experience in organic synthesis, materials chemistry, and chem/bio decontamination. He received his Ph.D. from the University of Florida in the areas of synthesis and characterization of conjugated poly-electrolytes and polymers with an emphasis on developing new polymerization methods. Upon completion of his Ph.D., he worked at the US Air Force Research Laboratory at Tyndall AFB, FL where he developed decontamination methods for chemical and biological threats and developed novel synthetic routes for reactive and functional surfaces.
Chief Financial OfficerOver the past 22 years, Jason Lewis has worked with ArrMaz, a global specialty chemical company in mining, fertilizer, phosphate, asphalt and oil and gas industries. For the past six years, Lewis has held the position of Vice President of Finance. He joined the company in a senior accounting role with cross-departmental work for sales, marketing and operations groups for seven years. Lewis has a strong track record of value creation by way of revenue growth through pricing, long-term customer contracts, cost optimization through analysis tools, negotiation of services, department restructuring, debt management and working capital reduction through controls and process improvements. He also has strong international experience including greenfield start-ups.
Chief Commercial OfficerPrior to joining Alexium, Allen Reihman worked for nine years at Invista, the world’s largest integrated fiber, resin, and intermediates company. As Director of New Business Development, Reihman was the entrepreneur for the successful commercialization of new specialty polymers. He led all phases of this innovation program, including product development, manufacturing, intellectual property, pricing strategies, branding, business planning, and strategic alliances. Additionally, Reihman served as Director of Commercial Development for five global specialty chemical businesses at Invista where he led growth initiatives, valuation and decision analysis, market research, and strategy development. Previously, Reihman worked for seven years at Eastman Chemical where he held a range of commercial leadership roles in corporate development, global P&L general management, innovation, and market development.
Board of Directors
Non-Executive ChairwomanSue Thomas has demonstrated a successful career as a technology entrepreneur, executive coach and governance specialist having established and grown Flexiplan before selling that company to MLC (now National Australia Bank) after originally qualifying in law as a solicitor in New South Wales. Thomas also has experience in capital markets, corporate strategy, governance and risk and is currently Chair of the Audit & Risk Committee of PEXA Limited and of Temple & Webster Limited (ASX:TPW). She is also a Director of Westpac subsidiaries in the financial services sector, including BT Portfolio Services and ASGARD Capital Management, and a Director of royalty company, Fitzroy River Holdings Limited (ASX:FZR). Previously, Thomas was a Director and Chair of Audit and Risk at Grant Thornton Australia Limited from 2011 to 2016. Based between Sydney and Perth, Thomas has also been a Senior Executive Coach since 2011 at Foresight Global Coaching having successfully coached C suite executives at ASX top 50 companies.
Brig. Gen. Stephen Cheney, USMC (Ret).
Non-Executive DirectorGeneral Stephen Cheney was a decorated Marine and is the former Inspector General of the Marine Corps and Commanding General of Parris Island Marine Base. He was appointed on April 15, 2015 to Alexium’s board. He is also the former Deputy Executive Secretary to U.S. Defense Secretary Dick Cheney and was also a member of Secretary of State John Kerry’s Foreign Affairs Policy Board. General Cheney serves as the chairman of Alexium’s Remuneration Committee.
Non-Executive DirectorClaire Poll is an experienced corporate director having led, over the past 20 years, strategy and corporate development for startup technology companies through to large multi-billion dollar companies in Australia, the UK and more recently the US as a Founding Executive for the October listing of Verona Pharma plc (Nasdaq:VRNA) for which Poll “rang the bell”. Poll, who originally qualified as a solicitor in Western Australia, has worked as a Director, general counsel and as a company secretary in public listed companies in the US, UK and Australia in the areas of venture capital, mobile satellite communications, internet services, software and biopharmaceuticals. Poll, who is based in Perth WA, started her corporate career with Burns Philp Company Limited, the diversified global company involved in food manufacturing, shipping and general trading. Poll also holds a post graduate diploma in Applied Corporate Finance, M&A and Advanced Industrial Equity Analysis.
Non-Executive DirectorRosheen Garnon (BEc (Accounting major), LLB, FCA, CTA, GAICD) has had a distinguished career in the accounting profession as a chartered accountant and taxation advisor. She was a senior partner with KPMG and held senior executive leadership roles with the Firm in Australia and at a global level. Garnon was a member of the KPMG Australian Executive Leadership Team for six years as the National Managing Partner for a significant client services division. She has extensive experience of working with Boards and C-Suite executives.
Garnon started her career with Peat Marwick Mitchell & Co (a predecessor firm of KPMG) in 1987 and was made partner in July 2000. She has extensive experience working with multinational organisations particularly in the mining, oil &gas, and defense industries. Garnon’s prominence in the accounting profession was recently recognized in her appointment to the Board of Taxation, an Independent Advisory Board, that advises the Federal Treasurer and Assistant Treasurer on Australia’s Taxation Policy.
Vice President, Investor RelationsMark Wise possesses more than 30 years of experience in investment markets and previously was a Portfolio Manager in New York, where he managed portfolios of Asian and Australian equities. Wise earned a Bachelor of Commerce degree with a focus in Accounting and Finance from the University of New South Wales in Sydney, Australia.
Alexium Acquires Reactive Surface Treatment (RST) Technology from US Air Force
Leveraging approximately $30M invested by the military to develop the chemical warfare and biological protection technology. Alexium wins 2009 World’s Best Technology.
Alexium Lists on ASX and Builds World-Class Team in Three Global Locations
Alexium lists on the Australian stock exchange. Creates a global team with operations in the USA, Australia, and Europe.
Alexium Builds Relationships and Rolls Out Cleanshell Technology
Alexium continues to build DoD and Natick relationships. Rolls out Cleanshell technology – a water and oil repellent treatment for textiles.
Alexium Announces Move to Flame Retardant (FR) Treatments and Expands Technical Team
After announcing to move into FR solutions, Alexium’s technology evolves and advances in a number of markets. Alexium also begins a global commercial roll-out of its FR treatments.
Alexium Continues to Expand Military Efforts
Alexium wins a contract with US Marine Corps to provide FR NyCo. Alexium experiences developmental breakthrough on FR NyCo, reaching 50-wash durability.
Alexium’s FR Technology Leads to Growth
Alexium prepares for commercialization in 2015, increasing staff to nearly 20. Developments on FR NyCo for military uniforms is underway and Alexium co-brands with iTextiles.
Alexium on the Rise to Optimal Growth
Alexium ramps up commercial growth while developing a team specialized in key roles throughout the organization. Alexium breaks into the plastics market ahead of schedule and passes stringent military FR specs. US DoD selects Alexium to finalize design and specifications for FR NyCo for military uniforms.
Alexium expands FR portfolio and launches PCM technology
Alexium breaks through the Phase Change Material (PCM) market with the successful launch of Alexicool and enhances its suite of Alexium FR products. Alexium continues to work with US Military on FR Uniforms with late-stage testing by Army and Marines. Alexium moves into a purpose-built facility equipped with innovative laboratories and offices as a result of the tremendous growth.
Strategic Growth Transitions Alexium to an Internationally Recognized Specialty Chemicals Developer
Traction in sales leads Alexium on the path towards cash neutrality. Major interest in Alexium’s proprietary chemistry results in a shift for an increase in reoccurring revenues and lucrative licensing deals. A strong shift towards eco-friendly and user-safe FR, alongside a strong presence of Alexium in the US Capitol, places Alexium in a competitive position for FR military uniform contracts. US operational growth and investor demand for Alexium stock results in OTC share conversion to the NASDAQ International Designation, a precursor to a NASDAQ main board listing.
We have offices in the US and Australia with distributors world-wide
Why Work at Alexium?
Alexium is committed to fostering a culture of personal growth and long-term career success. We recognize the importance of diversity and we celebrate our employee’s differences and similarities. We are rapidly enhancing our portfolio of offerings to provide more robust solutions to our customers. We place equal importance on investing in the future of our employees by offering competitive base compensation, comprehensive medical coverage, training and development opportunities. Benefits / Total Rewards At Alexium, we provide our employees with more than a salary. Total Rewards is everything you receive as an employee – your pay, comprehensive medical coverage, wellness programs and Employee Stock Ownership plan options.
- Health and Insurance
- Life Insurance
- Disability Insurance
Wellness Alexium provides you with tools and resources in the form of an Employee Assistance Program to help you achieve your physical, financial, and emotional wellness goals. Employee Stock Ownership Plan (ESOP) Eligible employees may share in the growth and prosperity of Alexium through employee ownership. All contributions to the ESOP are made by Alexium at no cost to employees. Alexium is an equal opportunity employer and is committed to diversity. M/F/Disability/Vet. Alexium is an E-Verify employer
2018 Corporate Governance and Directory
Alexium International Group Limited (“Company”) has adopted comprehensive systems of control and accountability as the basis for the administration of corporate governance. The Board of the Company is committed to administering the policies and procedures with openness and integrity, pursuing the true spirit of corporate governance commensurate with the Company’s needs.
To the extent they are applicable to the Company, the Board has adopted the Eight Corporate Governance Principles and Recommendations as published by ASX Corporate Governance Council (“ASX Corporate Governance Principles and Recommendations”).
The Company is pleased to make the following information on its corporate governance practices available below.